ArticleBiomolecules2022

PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.

Arianna Toscano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.